Phase 4 Osteoporosis trials recruiting now

All Osteoporosis trials, every phase

Other phases for Osteoporosis

Phase 4 Osteoporosis trials

• A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures
  NCT06864130 · Phase: Phase 4 · Ages: No age limits stated · Sex: Female · 7 locations
• Bone, Exercise, Alendronate, and Caloric Restriction
  NCT05764733 · Phase: Phase 4 · Ages: 60 Years and older · Sex: All (male and female) · 2 locations
• Combined Anabolic Therapy
  NCT06558188 · Phase: Phase 4 · Ages: 45 Years and older · Sex: Female · 1 location
• Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients
  NCT06938152 · Phase: Phase 4 · Ages: 50 Years to 90 Years · Sex: Female · 1 location
• Estrogen Supplementation and Bone Health in Women With CF
  NCT05704036 · Phase: Phase 4 · Ages: 0 Years to 100 Years · Sex: Female · 1 location
• GLP-1R Actions on Muscle and the Skeleton
  NCT07154719 · Phase: Phase 4 · Ages: 18 Years to 50 Years · Sex: All (male and female) · 2 locations
• Markers of Osteoporosis in Cystic Fibrosis
  NCT03921060 · Phase: Phase 4 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• Preserving Geriatric Muscle With an Osteoporosis Medication
  NCT06118905 · Phase: Phase 4 · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• RANK-ligand Inhibition to Combat Sarcopenia with Underlying Osteoporosis
  NCT06643780 · Phase: Phase 4 · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis
  NCT07283887 · Phase: Phase 4 · Ages: 50 Years to 80 Years · Sex: Female · 1 location
• Step-down Therapy After Long-term Osteoporosis Treatment
  NCT07281586 · Phase: Phase 4 · Ages: 50 Years to 85 Years · Sex: All (male and female) · 1 location
• StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis
  NCT06767150 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 17 locations
• The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation
  NCT07406685 · Phase: Phase 4 · Ages: 50 Years to 85 Years · Sex: Female · 1 location
• The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity
  NCT07271771 · Phase: Phase 4 · Ages: 40 Years and older · Sex: Female · 1 location
• The Optimised Use of Romozosumab Study
  NCT06059222 · Phase: Phase 4 · Ages: 50 Years and older · Sex: Female · 1 location

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.